Ferghana Partners Group
  • About
    • Firm
    • Team
  • Expertise
    • Acquisitions
    • Divestments
    • Financings
    • Partnering
  • Sector Focus
    • Biotechnology
    • Diagnostics/Tools
    • Medical Devices
    • OTC Drugs
    • Pharmaceuticals
    • Specialty Chemicals
  • Transactions
  • Media
  • Contact

Our Team

Ferghana’s team consists of experts from the biopharmaceutical, diagnostics, and medtech sectors plus experienced, innovative transactionists. Together, they seamlessly contribute to operational problem solving, transaction initiation, transaction execution and strategy deliberations for our clients.

Meet Our Team

Transactional Team

William J. Kridel, Jr

William J. Kridel, Jr

Managing Director
Rawle Michelson

Rawle Michelson

Managing Director
Stephen J. Bingham

Stephen J. Bingham

Director
James R. Erickson

James R. Erickson

Senior Transaction Advisor
Paul Thompson

Paul Thompson

Senior Transaction Advisor
Sandi Yurichuk

Sandi Yurichuk

Senior Transaction Advisor
Ulrich S. Koch

Ulrich S. Koch

Senior Transaction Advisor
Mark Bahreini

Mark Bahreini

Senior Analyst

Science and Clinical Affairs

Dr. Mitchell Ng

Dr. Mitchell Ng

Orthopedics
Thomas E. Malcolm, PhD

Thomas E. Malcolm, PhD

Gene Editing, Cell Therapy, Infectious Disease
Dr. Terrance C. Coyne

Dr. Terrance C. Coyne

Chief Medical Officer
Ken Kohn, PhD., JD

Ken Kohn, PhD., JD

Intellectual Property
Matthias Schroff, PhD

Matthias Schroff, PhD

Chief Scientific Officer
John Hurrell

John Hurrell

Diagnostics
Frank Tufaro, PhD

Frank Tufaro, PhD

Immunotherapy, Cancer, Bioproduction, Virology
Torben Skarsfeldt, PhD

Torben Skarsfeldt, PhD

Biopharmaceuticals & CNS
Ian Roberts

Ian Roberts

Science and Medical Affairs Advisor
Gregory E. Bobyock

Gregory E. Bobyock

OTC And Generic Drugs

Contact Us

CONTACT FERGHANA

  • Site Map
  • Contact
  • Home
COPYRIGHT 2018 | ALL RIGHTS RESERVED | View our Privacy policy.